Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
User

Thomas Graham, Alan, Irving Kahns

Kahn Brothers Group

Kahn Brothers Group Merck & Company Inc stake

total: 111

Kahn Brothers Group MRK trades

Total transactions:
52
New positions:
1
Added:
8
Reduced:
43
Held since:
2013 Q2 or earlier
Held for:
52+ quarters
Latest activity:
2026 Q1
According to 2026 Q1 report, Kahn Brothers Group holds 227,288 Merck & Company Inc (MRK) shares with a market value of roughly $27.34M accounting for 4.85% of the overall portfolio. Kahn Brothers Group has held MRK since at least 2013 Q2 with about 1.22M shares in our earliest available record. Since at least 2013 Q2, Kahn Brothers Group has made 51 more transactions.

How many MRK shares does Kahn Brothers Group currently hold?

According to 2026 Q1 report, Kahn Brothers Group holds 227,288 shares of Merck & Company Inc (MRK), valued at around $27.34M.

Estimated cost basis*

Weighted AVG buy price:
$12.66
Weighted AVG sell price:
$53.72

Kahn Brothers Group's historical trades in Merck & Company Inc

52 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q1
4.85%
227,288
$120.29
$27,340,511
-47.15% (-202,815)
-4.32%
2025 Q4
8.02%
430,103
$105.26
$45,272,674
-0.84% (-3,647)
-0.07%
2025 Q3
6.85%
433,750
$83.93
$36,404,663
-11.56% (-56,715)
-0.96%
2025 Q2
7.80%
490,465
$79.16
$38,825,234
-0.37% (-1,810)
-0.03%
2025 Q1
8.94%
492,275
$89.76
$44,187,086
-3.27% (-16,633)
-0.32%
2024 Q4
11.00%
508,908
$99.48
$50,626,737
-12.33% (-71,580)
-1.23%
2024 Q3
11.35%
580,488
$113.56
$65,920,748
-1.93% (-11,423)
-0.22%
2024 Q2
12.32%
591,911
$123.80
$73,278,768
-3.57% (-21,904)
-0.4%
2024 Q1
12.01%
613,815
$131.95
$80,992,904
-1.72% (-10,726)
-0.22%
2023 Q4
10.73%
624,541
$109.02
$68,087,714
-2.23% (-14,252)
-0.24%
2023 Q3
10.26%
$102.95
-1.52% (-9,878)
2023 Q2
10.97%
$115.39
-3.41% (-22,933)
2023 Q1
10.29%
$106.39
-1.49% (-10,159)
2022 Q4
9.96%
$110.95
-0.36% (-2,492)
2022 Q3
9.13%
$85.62
-2.11% (-14,769)
2022 Q2
8.58%
$91.17
+0.65% (+4,489)
2022 Q1
7.24%
$82.05
-2.07% (-14,689)
2021 Q4
7.47%
$76.64
+0.43% (+3,041)
2021 Q3
7.47%
$75.11
-1.42% (-10,146)
2021 Q2
7.98%
$77.77
+1.34% (+9,443)
2021 Q1
8.43%
$77.09
-3.31% (-24,204)
2020 Q4
10.43%
$81.80
-8.93% (-71,719)
2020 Q3
12.62%
$82.95
-13.21% (-122,175)
2020 Q2
12.09%
$77.33
-10.15% (-104,490)
2020 Q1
14.07%
$74.70
-0.83% (-8,580)
2019 Q4
11.45%
$90.95
-48.68% (-984,546)
2019 Q3
11.30%
$44.56
-81.05% (-8,648,511)
2019 Q2
11.19%
$8.38
+1,183.53% (+9,839,726)
2019 Q1
10.80%
$83.17
-5.39% (-47,377)
2018 Q4
11.02%
$69.58
-0.90% (-7,978)
2018 Q3
9.66%
$70.94
-1.15% (-10,337)
2018 Q2
8.66%
$60.70
-0.81% (-7,310)
2018 Q1
7.85%
$54.47
-1.61% (-14,822)
2017 Q4
8.13%
$56.27
+0.05% (+479)
2017 Q3
8.99%
$64.03
-1.51% (-14,110)
2017 Q2
9.12%
$64.09
-0.77% (-7,279)
2017 Q1
10.27%
$63.54
-1.32% (-12,622)
2016 Q4
9.47%
$58.87
-0.55% (-5,250)
2016 Q3
10.83%
$62.41
-0.72% (-6,934)
2016 Q2
10.76%
$57.61
-2.08% (-20,494)
2016 Q1
9.77%
$52.91
-2.52% (-25,508)
2015 Q4
9.54%
$52.82
+0.47% (+4,719)
2015 Q3
9.20%
$49.39
-1.02% (-10,405)
2015 Q2
9.76%
$56.93
-1.28% (-13,202)
2015 Q1
10.00%
$57.48
-2.18% (-22,992)
2014 Q4
10.31%
$56.79
-5.08% (-56,382)
2014 Q3
10.69%
$59.28
-0.97% (-10,885)
2014 Q2
9.43%
$57.85
-0.74% (-8,341)
2014 Q1
9.14%
$56.77
-55.32% (-1,396,961)
2013 Q4
5.21%
$11.99
+105.56% (+1,296,843)
2013 Q3
8.51%
$47.61
+1.06% (+12,874)
2013 Q2
8.71%
$46.45
new or own*
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.